News
President Donald Trump is unlikely to follow through on his threat to fire Federal Reserve Chairman Jerome Powell - but the pressure from his public campaign for lower interest rates will still have ...
But as Earth Day approaches, the decline in regulatory protections and support for energy transition leaves investors ...
The bad news is that President Donald Trump's latest threats against the independence of the Federal Reserve raise the risks to your investments. The threats themselves are bad enough. But the ...
Trump has slapped 25% tariffs on goods from both Mexico and Canada, but later suspended those levies on products that fall under the two countries' trade agreement with the U.S. Still, many products ...
If the recent past is any guide, an indicator known as the "Smart Money Flow Index" might be flashing a market buy signal, said Jim Paulsen, a market veteran and former top strategist at the Leuthold ...
Eli Lilly & Co.'s stock soared 14% Thursday, to put it on track for its biggest one-day gain in about 25 years, after the drugmaker reported positive results from a late-stage trial of a GLP-1 ...
The parent company of President Donald Trump's social-media platform, Truth Social, is on the warpath against "naked short selling" again as its stock has fallen, this time directing its sniping at a ...
Ahead of that announcement, most commodities, including gold and silver, were trading higher as speculators expected the tariffs to prove inflationary, Ash said. But the "reality of Trump's tariff war ...
It had become something of a cliché to say that investors hate uncertainty - at least until the confusion surrounding President Donald Trump's on-again, off-again tariff plans left them grasping for a ...
Active ETFs being cheaper lowers their hurdle rate, and lower fees are always going to tip the odds in investors’ favor. ETFs ...
Regeneron Pharmaceuticals and Sanofi won U.S. Food and Drug Administration expanded approval of their blockbuster anti-inflammatory drug Dupixent for the inflammatory skin condition chronic ...
Meta (META) has the second-lowest forward P/E among the largest 10 components of the S&P 500. Only Alphabet Inc. (GOOGL) trades lower. The Google holding company faces its own antitrust challenges, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results